These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16613668)

  • 1. [Survivin antisense RNA induces apoptosis and sensitizes ovarian cancer cell line SKOV3 to docetaxel].
    Ma R; Chen XH; Tang LP; Geng XX; Sui LH; Zhang YL
    Ai Zheng; 2006 Apr; 25(4):393-7. PubMed ID: 16613668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Exploration on the increased sensitivity to docetaxel and reversing mechanism of drug resistance of antisense survivin RNA in gastric cancer cell line SGC7901 cells].
    Ma R; Chen XH; Zhang QF; Zhu L; Tang LP; Wang J; Cheng HY; Lei LN
    Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):89-92. PubMed ID: 17645838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of antisense survivin RNA transfection on the growth of ovarian carcinoma SKOV3 cells in vitro and in vivo].
    Shi HR; Lan L; Qiao YH; Li KH; Hou LJ; Liu HX
    Zhonghua Fu Chan Ke Za Zhi; 2005 Dec; 40(12):831-5. PubMed ID: 16412330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of RNAi-mediated survivin gene silencing on apoptosis of ovarian cancer cell lines SKOV3 and SKOV3/ADM].
    Deng KX; Zhong L; Jiang MX; Chen WX; Chen Y; He H
    Ai Zheng; 2005 Aug; 24(8):945-50. PubMed ID: 16086871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of survivin siRNA on growth, apoptosis and chemosensitivity of ovarian cancer cells SKOV3/DDP].
    Zhang X; Li N; Wang YH; Huang Y; Xu NZ; Wu LY
    Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):174-7. PubMed ID: 19615253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of survivin shRNA on chemosensitivity of human ovarian cancer cell line OVCAR3 to paclitaxel].
    Yan XJ; Liang LZ; Zeng ZY; Shi Z; Fu LW
    Ai Zheng; 2006 Apr; 25(4):398-403. PubMed ID: 16613669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental therapy of survivin antisense oligonucleotide for human ovarian cancer cell SKOV3].
    Wei SQ; Bi S; Zheng JH; Zhang GM; Sui LH; Pan SH
    Ai Zheng; 2004 Aug; 23(8):890-5. PubMed ID: 15301709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of apoptosis in human ovarian epithelial cancer cells by antisurvivin oligonucleotides.
    Ma X; Wang S; Zhou J; Xing H; Xu G; Wang B; Chen G; Lu YP; Ma D
    Oncol Rep; 2005 Jul; 14(1):275-9. PubMed ID: 15944801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [RNA interference silencing expression of survivin gene and reversing drug resistance of ovarian cancer cell line SKOV3/ADM].
    Deng KX; Zhong L; Jiang MX; Wang PL; Chen Y
    Zhonghua Fu Chan Ke Za Zhi; 2005 Dec; 40(12):836-9. PubMed ID: 16412331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antisense RNA targeting survivin enhances the chemosensitivity of LOVO/Adr cells to taxotere].
    Lian YJ; Chen DD; Huang T
    Zhonghua Wei Chang Wai Ke Za Zhi; 2005 Sep; 8(5):455-8. PubMed ID: 16224667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibitory effects of survivin antisense oligonucleotide on drug-resistant human ovarian cancer cell COC1/DDP].
    Ruan F; Xie XK; Liu SY
    Ai Zheng; 2004 Aug; 23(8):896-9. PubMed ID: 15301710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of inhibiting survivin expression with antisense oligodeoxynucleotides on sensitivity of hepatocellular carcinoma cell lines HepG2 and HepG2/ADM to adriamycin].
    Dai DJ; Lu CD; Guo JM; Zhang J
    Ai Zheng; 2005 Aug; 24(8):951-7. PubMed ID: 16086872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of survivin antisense mRNA transfection on the growth and chemotherapy sensitivity of lymphoma cells].
    Gu X; Lin HL; Shao JY; Zhang M; Zhu YK; Liang HZ; Ma YH
    Zhonghua Bing Li Xue Za Zhi; 2005 Nov; 34(11):737-41. PubMed ID: 16536320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of down-regulation of survivin gene on apoptosis and cisplatin resistance in cisplatin resistant human lung adenocarcinoma A549/CDDP cells].
    Zhang MC; Hu CP; Chen Q
    Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):408-12. PubMed ID: 17152483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of survivin antisense oligonucleotides on survivin and Smac gene expression in ovarian cancer cells].
    Sun Y; Li Y; Fan LQ; Wu XH; Cheng JX; Zhao Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Oct; 27(10):1571-4. PubMed ID: 17959540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversing drug resistance in the ovarian carcinoma cell line SKOV3/mdr1 in vitro by antisense oligodeoxynucleotides.
    Pan L; Tong Y; Jin Y; Zhou S; Zhang Y; Yang X; Mao N
    Chin Med J (Engl); 2001 Sep; 114(9):929-32. PubMed ID: 11780384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on apoptosis of oral squamous carcinoma cell line KB and KBv200 induced by survivin RNAi].
    Yan L; Chen WQ; Liang YJ; Dai CL; Wang XH; Shi Z; Chen LM; Fu LW
    Ai Zheng; 2006 Aug; 25(8):933-40. PubMed ID: 16965671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combinative effects of FAP-1 antisense oligonucleotide and carboplatin on apoptosis of ovarian cancer cell SKOV3].
    Wang B; Zheng WG; Xin XY; Qi RY; Yu YC; Cao YX
    Ai Zheng; 2004 Aug; 23(8):885-9. PubMed ID: 15301708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of survivin gene repression by RNA interference on the radiosensitivity and chemosensitivity to cisplatin of cervical cancer cell HeLa].
    Song H; Xin XY; Xiao F; Wang DT; Han X; Guo HL
    Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):554-8. PubMed ID: 17083843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cisplatin resistant effects of dihydrofolate reductase gene expression up-regulation in epithelial ovarian cancer].
    Li Z; Wang Q; Zhang W; Yang Z; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2015 Nov; 50(11):854-60. PubMed ID: 26887775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.